Cargando…
Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions
BACKGROUND: The purpose of this study was to assess the safety and efficacy of oral glycopyrrolate solution 1 mg/5 mL for 24 weeks in pediatric patients with chronic moderate-to- severe drooling associated with cerebral palsy and other neurologic conditions. METHODS: In this multicenter, open-label,...
Autores principales: | Zeller, Robert S, Davidson, Jennifer, Lee, Hak-Myung, Cavanaugh, Paul F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269348/ https://www.ncbi.nlm.nih.gov/pubmed/22298951 http://dx.doi.org/10.2147/TCRM.S27362 |
Ejemplares similares
-
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions
por: Zeller, Robert S, et al.
Publicado: (2012) -
Oral glycopyrrolate for the treatment of chronic severe drooling caused by neurological disorders in children
por: Evatt, Marian L
Publicado: (2011) -
Glycopyrrolate for drooling in children with medical complexity under three years of age
por: Lovardi, Eleonora, et al.
Publicado: (2022) -
Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience
por: Zanon, Davide, et al.
Publicado: (2021) -
The association of drooling and health-related quality of life in children with cerebral palsy
por: Chang, Shih-Chung, et al.
Publicado: (2012)